These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12584571)

  • 1. Trans-activation of heparanase promoter by ETS transcription factors.
    Lu WC; Liu YN; Kang BB; Chen JH
    Oncogene; 2003 Feb; 22(6):919-23. PubMed ID: 12584571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1.
    Santiago FS; Khachigian LM
    Circ Res; 2004 Sep; 95(5):479-87. PubMed ID: 15297375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
    Lynch CC; Crawford HC; Matrisian LM; McDonnell S
    Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.
    Rutter JL; Mitchell TI; Butticè G; Meyers J; Gusella JF; Ozelius LJ; Brinckerhoff CE
    Cancer Res; 1998 Dec; 58(23):5321-5. PubMed ID: 9850057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN; Kang BB; Chen JH
    Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1.
    Hasegawa Y; Abe M; Yamazaki T; Niizeki O; Shiiba K; Sasaki I; Sato Y
    Biochem Biophys Res Commun; 2004 Mar; 316(1):52-8. PubMed ID: 15003510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
    Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
    Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
    Zhang M; Maass N; Magit D; Sager R
    Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.